Lung cancer in patients with human immunodeficiency virus infection

M. R. Flores, K. S. Sridhar, Richard J Thurer, M. Saldana, W. A. Raub, N. G. Klimas

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

This retrospective study determined the clinical course of lung cancer in patients with human immunodeficiency virus (IIIV) infection. A total of 23 patients with HIV infection archived as lung cancer were studied: 16 were identified from about 1,000 lung cancer patients entered in the tumor registry and medical records of Jackson Memorial Hospital, 7 were identified from about 1,000 HIV-positive patients entered in the Special Immunology registry of Veterans Administration Medical Center, 4 patients did not have pathologic confirmation of lung cancer, and 19 patients, all men, met the criteria for analysis (histopathologic diagnosis of lung cancer and HIV+ by serology). The median age was 47 (range: 3666). Risk factors for HIV were homosexuality (6 patients), blood transfusion (3), promiscuity (5), intravenous drug abuse (4), and none (3). Six patients had a history of coexistent pulmonary tuberculosis and 5 had Pneumocystis carinii pneumonia. Median survival from diagnosis of lung cancer was 3 months. Advanced stages of both HIV infection and lung cancer may account for the poor survival. All patients were men and noted to be younger than other patients with lung cancer.

Original languageEnglish
Pages (from-to)59-66
Number of pages8
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume18
Issue number1
StatePublished - Feb 7 1995

Fingerprint

Virus Diseases
Lung Neoplasms
HIV
HIV Infections
Registries
Intravenous Substance Abuse
United States Department of Veterans Affairs
Pneumocystis Pneumonia
Survival
Homosexuality
Serology
Allergy and Immunology
Pulmonary Tuberculosis
Blood Transfusion
Medical Records
HIV-1
Retrospective Studies

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Flores, M. R., Sridhar, K. S., Thurer, R. J., Saldana, M., Raub, W. A., & Klimas, N. G. (1995). Lung cancer in patients with human immunodeficiency virus infection. American Journal of Clinical Oncology: Cancer Clinical Trials, 18(1), 59-66.

Lung cancer in patients with human immunodeficiency virus infection. / Flores, M. R.; Sridhar, K. S.; Thurer, Richard J; Saldana, M.; Raub, W. A.; Klimas, N. G.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 18, No. 1, 07.02.1995, p. 59-66.

Research output: Contribution to journalArticle

Flores, MR, Sridhar, KS, Thurer, RJ, Saldana, M, Raub, WA & Klimas, NG 1995, 'Lung cancer in patients with human immunodeficiency virus infection', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 18, no. 1, pp. 59-66.
Flores MR, Sridhar KS, Thurer RJ, Saldana M, Raub WA, Klimas NG. Lung cancer in patients with human immunodeficiency virus infection. American Journal of Clinical Oncology: Cancer Clinical Trials. 1995 Feb 7;18(1):59-66.
Flores, M. R. ; Sridhar, K. S. ; Thurer, Richard J ; Saldana, M. ; Raub, W. A. ; Klimas, N. G. / Lung cancer in patients with human immunodeficiency virus infection. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 1995 ; Vol. 18, No. 1. pp. 59-66.
@article{c4efdf1eb2914509bcbf4a4a4edf3e6c,
title = "Lung cancer in patients with human immunodeficiency virus infection",
abstract = "This retrospective study determined the clinical course of lung cancer in patients with human immunodeficiency virus (IIIV) infection. A total of 23 patients with HIV infection archived as lung cancer were studied: 16 were identified from about 1,000 lung cancer patients entered in the tumor registry and medical records of Jackson Memorial Hospital, 7 were identified from about 1,000 HIV-positive patients entered in the Special Immunology registry of Veterans Administration Medical Center, 4 patients did not have pathologic confirmation of lung cancer, and 19 patients, all men, met the criteria for analysis (histopathologic diagnosis of lung cancer and HIV+ by serology). The median age was 47 (range: 3666). Risk factors for HIV were homosexuality (6 patients), blood transfusion (3), promiscuity (5), intravenous drug abuse (4), and none (3). Six patients had a history of coexistent pulmonary tuberculosis and 5 had Pneumocystis carinii pneumonia. Median survival from diagnosis of lung cancer was 3 months. Advanced stages of both HIV infection and lung cancer may account for the poor survival. All patients were men and noted to be younger than other patients with lung cancer.",
author = "Flores, {M. R.} and Sridhar, {K. S.} and Thurer, {Richard J} and M. Saldana and Raub, {W. A.} and Klimas, {N. G.}",
year = "1995",
month = "2",
day = "7",
language = "English",
volume = "18",
pages = "59--66",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Lung cancer in patients with human immunodeficiency virus infection

AU - Flores, M. R.

AU - Sridhar, K. S.

AU - Thurer, Richard J

AU - Saldana, M.

AU - Raub, W. A.

AU - Klimas, N. G.

PY - 1995/2/7

Y1 - 1995/2/7

N2 - This retrospective study determined the clinical course of lung cancer in patients with human immunodeficiency virus (IIIV) infection. A total of 23 patients with HIV infection archived as lung cancer were studied: 16 were identified from about 1,000 lung cancer patients entered in the tumor registry and medical records of Jackson Memorial Hospital, 7 were identified from about 1,000 HIV-positive patients entered in the Special Immunology registry of Veterans Administration Medical Center, 4 patients did not have pathologic confirmation of lung cancer, and 19 patients, all men, met the criteria for analysis (histopathologic diagnosis of lung cancer and HIV+ by serology). The median age was 47 (range: 3666). Risk factors for HIV were homosexuality (6 patients), blood transfusion (3), promiscuity (5), intravenous drug abuse (4), and none (3). Six patients had a history of coexistent pulmonary tuberculosis and 5 had Pneumocystis carinii pneumonia. Median survival from diagnosis of lung cancer was 3 months. Advanced stages of both HIV infection and lung cancer may account for the poor survival. All patients were men and noted to be younger than other patients with lung cancer.

AB - This retrospective study determined the clinical course of lung cancer in patients with human immunodeficiency virus (IIIV) infection. A total of 23 patients with HIV infection archived as lung cancer were studied: 16 were identified from about 1,000 lung cancer patients entered in the tumor registry and medical records of Jackson Memorial Hospital, 7 were identified from about 1,000 HIV-positive patients entered in the Special Immunology registry of Veterans Administration Medical Center, 4 patients did not have pathologic confirmation of lung cancer, and 19 patients, all men, met the criteria for analysis (histopathologic diagnosis of lung cancer and HIV+ by serology). The median age was 47 (range: 3666). Risk factors for HIV were homosexuality (6 patients), blood transfusion (3), promiscuity (5), intravenous drug abuse (4), and none (3). Six patients had a history of coexistent pulmonary tuberculosis and 5 had Pneumocystis carinii pneumonia. Median survival from diagnosis of lung cancer was 3 months. Advanced stages of both HIV infection and lung cancer may account for the poor survival. All patients were men and noted to be younger than other patients with lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0028966058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028966058&partnerID=8YFLogxK

M3 - Article

C2 - 7847261

AN - SCOPUS:0028966058

VL - 18

SP - 59

EP - 66

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -